Literature DB >> 16286432

Systematic review of studies of productivity loss due to rheumatoid arthritis.

Wayne Burton1, Alan Morrison, Ross Maclean, Eric Ruderman.   

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is a chronic, debilitating disease with a significant impact on workplace productivity. AIM: To perform a systematic review of studies of the relationship between RA and reduced workplace productivity.
METHODS: Screening of 307 titles identified in bibliographic database searches resulted in 38 articles subject to systematic review. Productivity loss was expressed by three different measures: work disability, work loss (synonymous with absenteeism or short-term sick leave) and work limitation (reduction in productivity while present at work).
RESULTS: A median of 66% (range 36-84%) of employed RA subjects experienced work loss due to RA in the previous 12 months, for a median duration of 39 days (range 7-84 days). The times from RA diagnosis until a 50% probability of being work disabled varied from 4.5 to 22 years. In inception cohort studies, the baseline variables consistently predictive of subsequent work disability were a physically demanding work type, more severe RA and older age.
CONCLUSIONS: RA-related work-disability rates were similar in the USA and European countries. An apparent decrease in the prevalence of RA-related work disability since the 1970s may be related to a decrease in physically demanding work rather than to epidemiologic changes in RA. The majority of the literature addresses permanent disability and temporary work loss; none of the studies reviewed reported the effect of RA on presenteeism, i.e. work limitation from the employer perspective, and there are few published studies of the effectiveness of disease-modifying anti-rheumatic drugs in reducing work-related productivity loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286432     DOI: 10.1093/occmed/kqi171

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  81 in total

Review 1.  Critical Appraisal of the Quality of Literature Evaluating Psychometric Properties of Arthritis Work Outcome Assessments: A Systematic Review.

Authors:  Rawan Alheresh; Molly Vaughan; Michael P LaValley; Wendy Coster; Julie J Keysor
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-27       Impact factor: 4.794

2.  Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats.

Authors:  Venkatesan Saratha; Sorimuthu Pillai Subramanian
Journal:  Inflammopharmacology       Date:  2011-10-16       Impact factor: 4.473

Review 3.  Employee health and presenteeism: a systematic review.

Authors:  Alyssa B Schultz; Dee W Edington
Journal:  J Occup Rehabil       Date:  2007-07-25

Review 4.  Exploring the diversity of conceptualizations of work (dis)ability: a scoping review of published definitions.

Authors:  Valérie Lederer; Patrick Loisel; Michèle Rivard; François Champagne
Journal:  J Occup Rehabil       Date:  2014-06

5.  Natural history of upper extremity musculoskeletal symptoms and resulting work limitations over 3 years in a newly hired working population.

Authors:  Bethany T Gardner; Ann Marie Dale; Alexis Descatha; Bradley Evanoff
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

6.  Influence of rheumatoid arthritis-related morning stiffness on productivity at work: results from a survey in 11 European countries.

Authors:  Kalle Mattila; Frank Buttgereit; Risto Tuominen
Journal:  Rheumatol Int       Date:  2015-05-26       Impact factor: 2.631

7.  How co-morbidities magnify the effect of arthritis on labour force participation and economic status: a costs of illness study in Australia.

Authors:  Deborah J Schofield; Emily J Callander; Rupendra N Shrestha; Megan E Passey; Richard Percival; Simon J Kelly
Journal:  Rheumatol Int       Date:  2014-02-22       Impact factor: 2.631

8.  Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample.

Authors:  Edward Yelin; Chris Tonner; Laura Trupin; Pantelis Panopalis; Jinoos Yazdany; Laura Julian; Patricia Katz; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-02-15

9.  Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US.

Authors:  Saralynn Allaire; Frederick Wolfe; Jingbo Niu; Michael P Lavalley
Journal:  Arthritis Rheum       Date:  2008-04-15

10.  Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry.

Authors:  M Cárdenas; S de la Fuente; P Font; M C Castro-Villegas; M Romero-Gómez; D Ruiz-Vílchez; J Calvo-Gutiérez; A Escudero-Contreras; M A Casado; J R Del Prado; E Collantes-Estévez
Journal:  Rheumatol Int       Date:  2016-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.